Mucipoly P Tablet: A High-Demand Product for Your PCD Pharma Franchise Portfolio

A Unique Combination for Respiratory Health

Therapeutic Uses and Market Demand for Mucipoly P Tablet

Why Pharma Wholesalers Choose Cafoli Lifecare for Respiratory Drugs

Quality, Efficacy, and Our Commitment to Your Success
How to Begin Your PCD Franchise with This Bestselling Tablet

Home/Products /acetylcysteine-300mg-pyridoxamine-dihydrochloride-50mg-tablet

About the Product

Description


Mucipoly P Tablet, with its unique and effective combination of Acetylcysteine (300mg) and Pyridoxamine dihydrochloride (50mg), is a highly sought-after product in the respiratory care segment. As a leading PCD pharma company in India, we understand that pharma distributors and wholesalers are always seeking high-demand products with a consistent market.

Acetylcysteine acts as a potent mucolytic agent, effectively breaking down thick mucus in the respiratory tract, which helps in the treatment of conditions like Chronic Obstructive Pulmonary Disease (COPD), bronchitis, and other respiratory illnesses. The addition of Pyridoxamine, a powerful antioxidant, helps to reduce oxidative stress and inflammation, providing a comprehensive approach to managing chronic respiratory conditions. This dual-action formula makes Mucipoly P a valuable asset for any healthcare professional and a profitable product for reselling.

At Cafoli Lifecare, we are committed to providing only the best. Our Mucipoly P Tablets are manufactured in state-of-the-art facilities with stringent quality controls, ensuring their efficacy and safety. By partnering with us, you get a premium product that is well-positioned in the market, along with dedicated support and competitive pricing. Secure your success in the wholesale pharma market by choosing Cafoli Lifecare as your trusted partner.

Generally well tolerated. May cause nausea, vomiting, abdominal discomfort, or mild allergic reactions. Rarely, rash or headache may occur.

Indicated for patients with chronic respiratory disorders involving mucus retention, and as adjunctive therapy in diabetic complications where oxidative stress plays a role.

Use only under medical supervision. Inform your doctor if you have asthma, peptic ulcers, or kidney issues. Do not exceed the prescribed dose.

Store below 25°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Acetylcysteine 300mg + Pyridoxamine Dihydrochloride 50mg Tablet in the PCD pharma franchise market?

This combination tablet has strong demand in the hepatology and antioxidant support segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on liver care, metabolic health, and oxidative stress management portfolios.

Why should medical distributors include this combination tablet in their product range?

Medical distributors and agencies can benefit from demand in liver protection and metabolic disorder support therapy. Acetylcysteine 300mg works as an antioxidant and mucolytic, while Pyridoxamine (Vitamin B6 derivative) helps in amino acid metabolism and reduces glycation-related oxidative damage, strengthening a comprehensive liver and metabolic care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this combination tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from steady hepatology prescription demand, growing lifestyle-related liver disorders, reliable supply chain support, and good margins when partnering for this combination product.

How can I become a distributor or franchise partner for this tablet?

Medical distributors, stockists, and wholesalers interested in this combination tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.